A Transvenous Endovascular Approach in Straight Sinus has Minor Impacts on Chordae Willisii

Yuanliang Ye1, Jiuyang Ding2, Shoutang Liu3

  • 1Department of Neurosurgery, Liuzhou People's Hospital, Liuzhou, Guangxi Autonomous Region; Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Neurology India
|September 9, 2022
PubMed

Insights

Transvenous endovascular procedures may cause minor damage to the chordae willisii (CW) in the straight sinus, particularly with stent use. Repeated navigation did not increase CW damage risk.

Area of Science:

  • Neurosurgery
  • Vascular Surgery
  • Medical Device Technology

Background:

  • Transvenous endovascular approaches are standard for cerebrovascular diseases.
  • Potential iatrogenic damage to chordae willisii (CW) in the straight sinus is a concern.
  • Limited literature addresses CW damage during these procedures.

Purpose of the Study:

  • Investigate potential damage to CW in the straight sinus during transvenous endovascular procedures.
  • Assess the impact of endovascular devices on CW integrity.

Main Methods:

  • Endoscopic observation of CW features in 38 cadaveric heads.
  • Mimicking mechanical thrombectomy procedures in the straight sinus.
  • Light microscopy to evaluate CW damage post-procedure.

Main Results:

  • Valve-like and longitudinal lamellae were observed, predominantly posteriorly.
  • Trabeculae were present in both anterior and posterior straight sinus.
  • Stent use showed a significantly higher rate of Grade 1 CW damage (P=0.02) and surface damage (P=0.00) compared to balloons.
  • Repeated procedures with stents or balloons did not increase CW damage rates.

Conclusions:

  • Stent and balloon navigation in the straight sinus can inflict minor CW damage.
  • Retrograde navigation does not appear to elevate the risk of CW damage.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
18
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
28
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
31
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
38
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
37